MeiraGTx Holdings plc financial data

Symbol
MGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
450 East 29 Th Street, 14 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 253 % +44.4%
Debt-to-equity 176 % -2.07%
Return On Equity -81 % +34.9%
Return On Assets -29.3 % +34%
Operating Margin -2.01K % -923%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.2M shares +22.9%
Common Stock, Shares, Outstanding 77.7M shares +30.4%
Entity Public Float 260M USD +7.12%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 71.6M shares +20.3%
Weighted Average Number of Shares Outstanding, Diluted 71.6M shares +20.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.9M USD +114%
Revenue from Contract with Customer, Excluding Assessed Tax 6.69M USD -84.2%
Research and Development Expense 129M USD +40.6%
Selling and Marketing Expense 12M USD
General and Administrative Expense 49.3M USD +0.16%
Operating Income (Loss) -176M USD -31.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -88.2M USD +33%
Earnings Per Share, Basic -1.23 USD/shares +50.2%
Earnings Per Share, Diluted -1.23 USD/shares +50.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 123M USD +93.9%
Accounts Receivable, after Allowance for Credit Loss, Current 3.28M USD -85.4%
Other Assets, Current 713K USD -5.94%
Assets, Current 139M USD +34.3%
Other Long-term Investments 1.5M USD 0%
Property, Plant and Equipment, Net 113M USD +0.59%
Operating Lease, Right-of-Use Asset 12.8M USD -26.7%
Intangible Assets, Net (Excluding Goodwill) 951K USD -16.6%
Other Assets, Noncurrent 1.14M USD -19.8%
Assets 299M USD +12.1%
Accounts Payable, Current 29.5M USD +42%
Accrued Liabilities, Current 19.3M USD -31.5%
Liabilities, Current 59.4M USD -6.45%
Deferred Income Tax Liabilities, Net 184K USD +7.6%
Operating Lease, Liability, Noncurrent 9.61M USD -32.6%
Liabilities 204M USD +16.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.85M USD -168%
Retained Earnings (Accumulated Deficit) -663M USD -15.4%
Stockholders' Equity Attributable to Parent 95.7M USD +4.19%
Liabilities and Equity 299M USD +12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.7M USD +1.74%
Net Cash Provided by (Used in) Financing Activities -1.27M USD -3.17%
Net Cash Provided by (Used in) Investing Activities 27.3M USD
Common Stock, Shares Authorized 1.29B shares 0%
Common Stock, Shares, Issued 77.7M shares +30.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 125M USD +94.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.95M USD +87.9%
Deferred Tax Assets, Valuation Allowance 126M USD +8.31%
Deferred Tax Assets, Gross 131M USD +4.83%
Operating Lease, Liability 13.8M USD -24.8%
Payments to Acquire Property, Plant, and Equipment 1.68M USD -80.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -100M USD +28.3%
Lessee, Operating Lease, Liability, to be Paid 16M USD -28.1%
Property, Plant and Equipment, Gross 149M USD +15.1%
Operating Lease, Liability, Current 4.18M USD +2.22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.36M USD -2.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.31M USD -7.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.18M USD -43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.55M USD +2.06%
Deferred Tax Assets, Operating Loss Carryforwards 70.7M USD -4.98%
Unrecognized Tax Benefits 2.03M USD +117%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.62M USD -68.6%
Operating Lease, Payments 5.61M USD +0.65%
Additional Paid in Capital 763M USD +15.8%
Depreciation, Depletion and Amortization 3.28M USD +5.92%
Share-based Payment Arrangement, Expense 26M USD -5.54%
Interest Expense 13.3M USD +4.88%